SUBSTITUTION THERAPY FOR HEROIN ADDICTION

REFERENCES

• Dole V.P. Addictive Behaviour. Sci. Am. 1980; 243(6)136–143
   Google Scholar
• Bammer G., Dobler-Mikola A., Fleming P.M., Strang J., Uchtenhagen A. The Heroin Prescribing Debate: Integrating Science and Politics. Science 1999; 284(5418)1277–1278
   PubMed Web of Science ®Google Scholar
• The authors are aware that this journal's policy and preference is to associate “abuse” to living organisms and “use” or “misuse” to objects. The field of “substance abuse” continues to use this term.
   Google Scholar
• Bell J., Ward J., Mattick R.P., Hay A., Chan J., Hall W. An evaluation of Private Methadone Clinics. National Drug Strategy Research Report No 4. Australian Government Publishing Service: Canberra, 1995
   Google Scholar
• McClellan A.T., Luborsky L., Woody G.E., O'Brien C.P., Kron R. Are the “Addiction-related” Problems of Substance Abusers Really Related?. J. Nerv. Ment. Dis. 1984; 169: 232–239
   Google Scholar
• Darke S., Swift W., Hall W. Prevalence, Severity and Correlates of Psychological Morbidity Among Methadone Maintenance Clients. Br. J. Addiction 1994; 87: 771–776
   Google Scholar
• Methadone Maintenance Treatment and Other Opioid Replacement Therapies, J. Ward, R.P. Mattick, W. Hall. Harwood Academic Publishers, Amsterdam 1998
   Google Scholar
• Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G. Buprenorphine versus Methadone in the Treatment of Opioid Dependence: Self-report, Urinalysis, and Addiction Severity Index. J. Psychopharmacol. 1996; 16(1)58–67
   Google Scholar
• Perneger T.V., Giner F., del Rio M. Randomized Trial of Heroin Maintenance Programmer for Addicts Who Fail in Conventional Drug Treatment. Br. Med. J. 1998; 317: 13–18
   PubMed Web of Science ®Google Scholar
• Terry C.E., Pellens M. The Opium Problem. Bureau of Social Hygiene, New York 1928
   Google Scholar
• Strang J. The British System: Past, Present and Future. Int. Rev. Psychiatry, 1989; I: 109–120
   Google Scholar
• Brain Report (Interdepartmental Committee on Drug Addiction). Drug Addiction—Second Report. HMSO, London 1965
   Google Scholar
• Stimpson J.V. AIDS and Injecting Drug Use in the U.K. 1987–1993: The Policy Response and the Prevention of the Epidemic. Soc. Sci. Med. 1995; 41(5)699–916
   Google Scholar
• Martin E. Prescribing Injectable Opiates. Substance Misuse Gen. Pract. 1997; 4
   Google Scholar
• Department of Health. Drug Misuse and Dependence—Guidelines on Clinical Management. HMSO, London 1999
   Google Scholar
• Sarfraz A., Alcorn R.J. Injectable Methadone Prescribing in the United Kingdom—Current Practice and Future Policy Guidelines. Substances Use Misuse 1999; 34(12)1709–1721
   Web of Science ®Google Scholar
• Drake R.E., Yovetich N.A., Bebout R.R. Integrated Treatment for Dually Diagnosed Homeless Adults. J. Nerv. Ment. Dis. 1997; 185: 289–305
   Google Scholar
• Weaver T., Renton A., Stimpson G., Tyrer P. Severe Mental Illness and Substance Misuse Co-morbidity: Research is Needed to Inform Policy and Service Development (Editorial). Br. Med. J. 1999; 318: 137–138
   PubMed Web of Science ®Google Scholar
• Strang J., Clee W.B., Gruer L., Raistrick D. Why Britain's Drug Czar Mustn't Wage War on Drugs. Br. Med. J. 1997; 315: 325–326
   Google Scholar
• Giffen J.P., Endicott S., Lambert S. Panic and Indifference—The politics of Canada's Drug Laws. Canadian Centre on Substance Abuse, Ottawa 1991
   Google Scholar
• Halliday R. Management of the Narcotic Addict. Br. Columbia Med. J. 1963; 5: 412–414
   Google Scholar
• Paulus I., Halliday R. Rehabilitation and the Narcotic Addict: Results of a Comparative Methadone Withdrawal Program. Can. Med. Assoc. J. 1967; 96: 655–659
   PubMed Web of Science ®Google Scholar
• Fischer B. Prescriptions, Power and Politics: the Turbulent History of Methadone Maintenance in Canada. J. Public Health Policy
   Google Scholar
• Information Canada. Commission of Inquiry into the Non-Medical Use of Drugs. Final Report. Information Canada, Ottawa 1973
   Google Scholar
• Fischer B., Rehm J. The Case for a Heroin Substitution Treatment Trial in Canada. Can. J. Public Health, 1997; 88(6)367–370
   PubMedGoogle Scholar
• Bishop J.W. Methadone and the Care of the Narcotic Addict: Report of a Special Joint Committee of C.M.A. and the D.N.H.W. Food and Drug Directorate. Can. Med. Assoc. J., 105: 1193–1201, December 4
   Google Scholar
• Peachey J.E., Franklin T. Methadone Treatment of Opiate Dependence in Canada. Br. J. Addiction 1985; 80: 291–299
   Google Scholar
• Brands J., Brands B., Marsh D. The Expansion of Methadone Prescribing on Ontario, 1996–1997. Addiction Res
   Google Scholar
• The College of Physicians and Surgeons in Ontario/Addiction Research Foundation. Methadone Maintenance Guidelines. CPSO/ARF, Toronto 1996
   Google Scholar
• Fischer B., Bisceglia D., Daniel N., Gliksman L. Methadone Treatment in Ontario (Canada)—Results of a Physician Survey. J. Maint. Addictions
   Google Scholar
• Hankins C. HIV, AIDS and Injection Drug Use: A National Action Plan. Health Canada, Ottawa 1997
   Google Scholar
• Strathdee S., Patrick D., Currie S., Cornelisse P., Rekart M., Montaner J., Schechter M., O'Shaughnessy M. Needle Exchange is Not Enough: Lessons from the Vancouver Injecting Drug Use Study. AIDS 1997; 11: 59–65
   PubMed Web of Science ®Google Scholar
• Fischer B., Rehm J., Blitz-Miller T. Lessons Not Learned? Injection Drug Use-related Harms and the Coverage and Reach of Harm Prevention Measures: A Comparison Between Canada and Select Western European Jurisdictions. Can. Med. Assoc. J
   Google Scholar
• Hankins C. Syringe Exchange in Canada: Good but Not Enough to Stem the HIV Tide. Substance Use Misuse 1998; 33: 1129–1146
   PubMed Web of Science ®Google Scholar
• Wall R., Rehm J., Fischer B., Brands B., Gliksman L., Stewart J., Medved W., Blake J. Social Costs of Un-treated Opioid Dependence. J. Urban Health
   Google Scholar
• Personal communication with Dr. Haim Mell, Director of Treatment and Rehabilitation Services, Israel Anti-drug Authority, 1998.
   Google Scholar
• Presented to the Drug Committee of the Israeli Parliament. Prison Report. Tel-Aviv, 1997
   Google Scholar
• Tzifroni C. The Danger Between Drunkenness and Addiction. Public Health 1977; 19(4)421–428
   Google Scholar
• Winick H.Z. Laws Relating to the Use of and Dependency on Habituating and Intoxicating Medications. Public Health 1977; 19(4)434–440
   Google Scholar
• There was an estimated increase from the 450 known, treated prescription opiate users, in the 1970s, to more than 2000 opiate users in 1977.[41]
   Google Scholar
• Miller L. Drug Addiction and Its Treatment. Introduction. Public Health 1977; 19(4)381–383
   Google Scholar
• Reiter M. Treating Drug Addicts in Israel. Drugs: Facts, Questions and Problems, D. Green. Ministry of Defense, Israel 1995; 375–406
   Google Scholar
• A committee created in 1977, headed by Prof. Baruch Padeh, Minister of Health.
   Google Scholar
• It is reasonable to consider that this heroin—locally grown and known as “Persian Coke” (“cocaine”)—entered Israel through the “Good Neighbor Fence” between Lebanon and northern Israel; a border which had been relatively closed until this time. Police files note that there were 547 adjudicated drug cases in 1967; 729 in 1968, and 2542 in 1973.
   Google Scholar
• Initially this was done by a private pharmacist, protected by Border Police, during the hours that his pharmacy was closed, at the national garbage dump, near the national airport.[46] When this methadone dispensing process was closed down a private medical clinic took its place as a methadone dispenser.
   Google Scholar
• Einstein S. Institutionalized Chemical Control: A Case Study of Pseudo-treatment of a Dehumanized-“patient” Deviant Population. Soc. Pharmacol. 1987; 1(3)251–278
   Google Scholar
• Reiter M. Drug Addiction Treatment. Public Health 1977; 19(4)385–396
   Google Scholar
• Inter-ministerial. Inter-agency Committee for the Comprehensive Treatment of Drugs, Jerusalem 1983
   Google Scholar
• Funded by both the ADA and the Ministry of Labor Social Affairs these are non-profit NGOs.
   Google Scholar
• Personal communication with the directors of each of the methadone treatment programs, 1999.
   Google Scholar
• Personal communication with the director of the Israeli prison methadone treatment program, 1998.
   Google Scholar
• Inserm 1990.
   Google Scholar
• Cour des Comptes, rapport public, July 1998. Official Journal Publications.
   Google Scholar
• Interministerial Mission in charge of the struggle on drug and traffic. Depends on French Prime Minister. Plan for 1999/2001. MILDT:
   Google Scholar
• Office Central pour la Répression du Trafic Illicite de Stupéfiants (Central Office in Charge of the Repression of Drug Trafficking). Annual Report 1999. OCRTIS, Paris 1999
   Google Scholar
• SUBTARES. EVAL Retrospective Study with 300 Drug Users Patients in Four Networks. 1999
   Google Scholar
• SPESUB. An EVAL research with 919 opioid drug addicted patients included by 101 general practitioners in a cohort study, A 2 years follow up study, (1997/1999); for the Ministry of Health. SPESUB, Paris
   Google Scholar
• Ministry of Justice. Direction of Statistics and Studies. Ministry of Justice, Paris 1999
   Google Scholar
• Harris Medical International. Impact of Substitution Programs (1995–1997). Study for Schering-Plough. 1998
   Google Scholar
• McKetin R., Darke S., Hayes A., Rumbold G. Drug Trends 1998. A Comparison of Drug Use and Trends in Three Australian States: Findings from the Illicit Drug Reporting System (IDRS). Monograph No. 41, National Drug and Alcohol Research Centre, Sydney 1999
   Google Scholar
• Wodak A. Harm Reduction: Australia as a Case Study. Bull. NY Acad. Med. 1995; 72(2)339–347
   Google Scholar
• Hall W., Darke S. Trends in Opiate Overdose Deaths in Australia 1979–1995. Proceedings of an International Opioid Overdose Symposium, Sydney, Australia, 14–15 August, 1997, W. Hall. Monograph #35, National Drug and Alcohol Research Centre, Sydney 1998
   Google Scholar
• Lintzeris N., Lenne M., Ritter A. Methadone Injecting in Australia: a Tale of Two Cities. Addiction 1999; 94(8)1175–1178
   PubMedGoogle Scholar
• ISSD 1996.
   Google Scholar
• Farrell M., Neeleman J., Griffiths P., Howes S., Strang J. (1998) Fatal Methadone and Heroin Deaths in the United Kingdom: A Growing Problem?. Proceedings of an International Opioid Overdose Symposium, SydneyAustralia, August, 14–151997, W. Hall. National Drug and Alcohol Research Centre, Sydney, Monograph #35
   Google Scholar
• Neelman J. J. Epidemiol. Commun. Health 1997; 51(4)435–437
   Google Scholar
• Zador D., Sunjic S., Darke S. Heroin-related Deaths in NSW, 1992; Toxicological Findings and Circumstances. Med. J. Australia 1996; 64: 204–207
   Google Scholar
• Hunt D.A., Lipton D.S., Goldsmith D.S., Strug D.L., Spunt B. It Takes Your Heart: The Image of Methadone Maintenance in the Addict World and Its Effect on Recruitment into Treatment. Int. J. Addictions 1985–86; 20(11&12)1751–1771
   Google Scholar
• Lidz C.W., Walker A.L. Therapeutic Control of Heroin: Dedifferentiating Legal and Psychiatric Controls. Soc. Inquiry 1977; 47: 294–321
   Google Scholar
• Ausubel D.P. Methadone Maintenance Treatment: the Other Side of the Coin. Int. J. Addictions 1983; 18(6)851–862
   PubMed Web of Science ®Google Scholar
• Newman R.G. A Success Story—Waiting to be Retold; Methadone Treatment in New York City. Bull. NY Acad. Med. 1993; 70: 135–145
   Google Scholar
• Newman R.G. Methadone Treatment. Defining and Evaluating Success. N. Engl. J. Med. 1987; 317: 447–450
   PubMed Web of Science ®Google Scholar
• D'Aunno. 1992
   Google Scholar
• Drucker E. Drug Prohibition and Public Health: 25 Years of Evidence. Public Health Rep. 1999; 114(1)14–29
   PubMed Web of Science ®Google Scholar
• Dole V.P. Hazards of Process Regulation. The Example of Methadone Maintenance. J. Am. Med. Assoc. 1992; 267: 2234–2235
   PubMed Web of Science ®Google Scholar